Wealth Enhancement Advisory Services’s Fulcrum Therapeutics FULC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-10,254
Closed -$35.9K – 4305
2026
Q2
$35.9K Buy
+10,254
New +$62.4K ﹤0.01% 3966

Other funds holding FULC

Wealth Enhancement Advisory Services's FULC Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of Fulcrum Therapeutics (FULC) in Q3 2026, closing a stake of 10,254 shares — an estimated $35.9K sold.

Wealth Enhancement Advisory Services first reported a position in FULC in Q2 2026 and held it in 1 quarter. The position peaked at $35.9K in Q2 2026. 151 funds tracked by Wall St. Rank hold FULC as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining Fulcrum Therapeutics position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 10,254 Fulcrum Therapeutics shares in Q3 2026, an estimated $35.9K.
  • Wealth Enhancement Advisory Services first reported a position in Fulcrum Therapeutics in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's Fulcrum Therapeutics position peaked at $35.9K in Q2 2026.
  • 151 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.